Vizhli Pharma Private Limited
About Vizhli Pharma Private Limited
Data last updated:
Vizhli Pharma Private Limited is a private limited company based in Namakkal, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U52310TZ2010PTC016390. Its GSTIN is 33AAJFV8593J1ZG (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Murugesan Sankarasubramanian and Sivakumar Venkataraman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.65 Lakh. For the same year it recorded a net profit of ₹2.68 Lakh (net margin 4%) and EBITDA of ₹3.86 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vizhli Pharma Private Limited
The main business activity of Vizhli Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vizhli Pharma Private Limited FY 2025 filings available
Vizhli Pharma Private Limited reported revenue of ₹67.65 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vizhli Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vizhli Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.86 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vizhli Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vizhli Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vizhli Pharma Private Limited
Vizhli Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murugesan Sankarasubramanian | Director | 22 Sep 2010 | 16 Years 0 Months | Current |
| Sivakumar Venkataraman | Director | 22 Sep 2010 | 16 Years 0 Months | Current |
| Ragupathy Appavu | Director | 22 Sep 2010 | 16 Years 0 Months | Current |
| Ramesh Palaniappan | Director | 22 Sep 2010 | 16 Years 0 Months | Current |
Peer Comparison of Vizhli Pharma Private Limited
Vizhli Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curific Lifesciences Private Limited | ₹67.99 Lakh (FY 2024) | •••• | •••• | 99.0% | •••• | Patna, Bihar, India |
| Richer and Swessary Chemicals Private Limited | ₹67.92 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Bhopal, Madhya Pradesh, India |
| Orisun Lifesciences Private Limited | ₹67.82 Lakh (FY 2024) | •••• | •••• | 94.0% | •••• | Panvel, Maharashtra, India |
| Be Pharmaceuticals Private Limited | ₹67.68 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Hyderabad, Telangana, India |
| Cassel Research Laboratories Private Limited | ₹67.67 Lakh (FY 2023) | •••• | •••• | 180.0% | •••• | Chennai, Tamil Nadu, India |
| Vizhli Pharma Private Limited this company | ₹67.65 Lakh (FY 2025) | •••• | •••• | •••• | Namakkal, Tamil Nadu, India | |
| Iaan Healthcare Private Limited | ₹67.56 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Panchkula, Haryana, India |
| Traumen Life Sciences Private Limited | ₹67.55 Lakh (FY 2022) | •••• | •••• | 43.0% | •••• | Virar West, Maharashtra, India |
| Medox Remedies Private Limited | ₹67.35 Lakh (FY 2022) | •••• | •••• | 30.0% | •••• | New Delhi, Delhi, India |
| Oricare Pharma Private Limited | ₹67.23 Lakh (FY 2023) | •••• | •••• | 0.0% | •••• | Ahmedabad, Gujarat, India |
| Cinstruments Private Limited | ₹67.15 Lakh (FY 2025) | •••• | •••• | 124.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Vizhli Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vizhli Pharma Private Limited
Vizhli Pharma Private Limited is audited by TSSK & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TSSK & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Vizhli Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vizhli Pharma Private Limited
Vizhli Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vizhli Pharma Private Limited
Employment history and EPFO contributions of people linked to Vizhli Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vizhli Pharma Private Limited
Vizhli Pharma Private Limited has 4 board changes on record since 2010: 4 appointments. The latest: Murugesan Sankarasubramanian was appointed as Director on 22 Sep 2010.
Credit Ratings, Litigation & Regulatory Alerts for Vizhli Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vizhli Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vizhli Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vizhli Pharma Private Limited
Vizhli Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAJFV8593J1ZG | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vizhli Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vizhli Pharma Private Limited
Vizhli Pharma is an active private limited company based in Namakkal, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 September 2010 (16+ years old) and is registered under CIN U52310TZ2010PTC016390.
Vizhli Pharma reported revenue of ₹67.65 Lakh for FY 2025.
Vizhli Pharma has 4 current directors:
- Murugesan Sankarasubramanian - Director
- Sivakumar Venkataraman - Director
- Ragupathy Appavu - Director
- Ramesh Palaniappan - Director
Vizhli Pharma reported a net profit of ₹2.68 Lakh (net margin 4%) and EBITDA of ₹3.86 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vizhli Pharma is 10% over three years and 7% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vizhli Pharma is 33AAJFV8593J1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Vizhli Pharma is U52310TZ2010PTC016390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vizhli Pharma was incorporated on 22 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Vizhli Pharma by revenue are Curific Lifesciences Private Limited, Richer and Swessary Chemicals Private Limited, Orisun Lifesciences Private Limited, Be Pharmaceuticals Private Limited, Cassel Research Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Murugesan Sankarasubramanian was appointed as Director on 22 Sep 2010. Ragupathy Appavu was appointed as Director on 22 Sep 2010. Ramesh Palaniappan was appointed as Director on 22 Sep 2010. Vizhli Pharma has 4 board changes on record in total.
The registered office of Vizhli Pharma is at 4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001.